About
CellaVision AB is an internationally leading company in the development of systems for automated cell imaging and analysis, founded in 1994 in Lund, Sweden.
Annual results
Reported figures, SEK · revenue up 4.8% in 2025
| Year | Revenue | Net income | Net margin | Free cash flow |
|---|---|---|---|---|
| 2025 | 758M | 153M | 20.2% | — |
| 2024 | 723M | 140M | 19.4% | — |
| 2023 | 677M | 130M | 19.2% | — |
| 2022 | 639M | 118M | 18.5% | — |
| 2021 | 565M | 125M | 22.1% | — |
Dividends per share
2026 2.75 SEK2025 2.50 SEK2024 2.25 SEK2023 2.25 SEK2022 2.00 SEK
CEVI.ST in MarketPulse
The live chart with RSI and moving averages, the price, news, signals and price alerts for CellaVision AB are inside MarketPulse — currently in private beta.
Company data by Eulerpool. Logos provided by Elbstream. Reported figures, not investment advice.